BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594 [PMID: 27920479 DOI: 10.3748/wjg.v22.i43.9586]
URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm
Number Citing Articles
1
Mingrong Ou, Weiming Zhang, Wen Zhang, Jianmin Guo, Rui Huang, Jian Wang, Jiacheng Liu, Juan Xia, Chao Wu, Yijia Zhu, Yuxin Chen. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B PatientsACS Omega 2024; 9(14): 16716 doi: 10.1021/acsomega.4c00780
2
Na-Ling Kang, Jie-Min Zhang, Yu-Rui Liu, Su Lin, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu, Da-Wu Zeng. Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infectionClinics and Research in Hepatology and Gastroenterology 2020; 44(1): 57 doi: 10.1016/j.clinre.2019.04.001
3
Vitalij А. Datsko, Larisa Ya. Fedoniuk, Yana I. Ivankiv, Khristina I. Kurylo, Аlina S. Volska, Sergij L. Malanchuk, Оleksandra М. Oleshchuk. EXPERIMENTAL CIRRHOSIS: LIVER MORPHOLOGY AND FUNCTIONWiadomości Lekarskie 2020; 73(5): 947 doi: 10.36740/WLek202005120
4
Salim Neşelioğlu, Esra Fırat Oğuz, Özcan Erel. Development of a New Colorimetric, Kinetic and Automated Ceruloplasmin Ferroxidase Activity Measurement MethodAntioxidants 2022; 11(11): 2187 doi: 10.3390/antiox11112187
5
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease ProgressionFuture Science OA 2018; 4(1) doi: 10.4155/fsoa-2017-0083
6
Mohammed Hussein Habeeb, Mufeed Jalil Ewadh, Mazen Jaafer Mousa. Ceruloplasmin Activity and Ferritin in Patients with Chronic Liver DiseaseMedical Journal of Babylon 2021; 18(3): 257 doi: 10.4103/MJBL.MJBL_32_21
7
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patientsWorld Journal of Gastroenterology 2020; 26(27): 3948 doi: 10.3748/wjg.v26.i27.3948
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
8
Minhui Dong, Jingwen Wu, Xueping Yu, Jing Li, Sisi Yang, Xun Qi, Richeng Mao, Yongmei Zhang, Jie Yu, Haoxiang Zhu, Feifei Yang, Yanli Qin, Jiming Zhang. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patientsLiver International 2018; 38(9): 1562 doi: 10.1111/liv.13688
9
Takashi Himoto, Tsutomu Masaki. Current Trends of Essential Trace Elements in Patients with Chronic Liver DiseasesNutrients 2020; 12(7): 2084 doi: 10.3390/nu12072084
10
J. Cao, X. Qi, N. Wang, Y. Chen, B. Xie, C. Ma, Z. Chen, W. Xiong. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves’ orbitopathyJournal of Endocrinological Investigation 2023; 46(10): 2005 doi: 10.1007/s40618-023-02033-3
11
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patientsWorld Journal of Gastroenterology 2020; 26(27): 3952-3962 doi: 10.3748/wjg.v26.i27.3952
12
Maria Tampaki, Nikolaos K. Gatselis, Spyridon Savvanis, Emmanouil Koullias, Asterios Saitis, Stella Gabeta, Melanie Deutsch, Emmanouil Manesis, Georgios N. Dalekos, John Koskinas. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centersEuropean Journal of Gastroenterology & Hepatology 2020; 32(12): 1545 doi: 10.1097/MEG.0000000000001670